当前位置： SCI文献检索 > HIV MEDICINE期刊下所有文献 > Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis.

Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis.

Abstract：

:Despite advances in the treatment of HIV disease, the incidence and mortality of invasive cryptococcal disease remain significant. A matched, case-control study was performed to examine the impact of highly active antiretroviral therapy (HAART) and azole use on the incidence of invasive cryptococcal disease in HIV-infected patients. The study was performed at a metropolitan hospital with a large indigent population and an incidence of seven cases of cryptococcal disease per 1000 persons with AIDS. Bivariate analysis, matched on CD4 count, revealed that both HAART use [odds ratio (OR) 0.43; 95% confidence interval (CI) 0.23-0.99] and azole use (OR 0.14; 95% CI 0.06-0.34) had a protective effect. Conditional logistic regression stratified on CD4 lymphocyte count revealed a protective role for azole use (OR 0.15; 95% CI 0.06-0.40) but not for HAART use (OR 0.47; 95% CI 0.18-1.26). Of note, the prevalence of HAART use was low in both cases and controls, with only 12% of cases and 23% of controls on HAART. The results of this study support previous evidence that azole use prevents invasive cryptococcal disease. Although current guidelines for the prophylaxis of opportunistic infections do not suggest routine prophylaxis for cryptococcal infection, this issue should be reconsidered, especially in populations that have a low prevalence of HAART use.

journal_name

HIV Med

journal_title

HIV medicine

authors

Cantey PT,Stephens DS,Rimland D

doi

10.1111/j.1468-1293.2005.00289.x

keywords:

subject

Has Abstract

pub_date

2005-07-01 00:00:00

pages

253-9

issue

4

eissn

1464-2662

issn

1468-1293

pii

HIV289

journal_volume

6

pub_type

杂志文章

相关文献

HIV MEDICINE文献大全
  • Cushing's syndrome secondary to inhaled corticosteroids mimicking HIV-associated lipodystrophy.

    abstract：:We report the case of an asthmatic man with HIV infection who was initially diagnosed with HIV treatment-associated lipodystrophy. Further investigations showed he had Cushing's syndrome secondary to 1600 microg of budesonide dry powder inhaler. Cushing's syndrome has not been reported previously on this normal dose o...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1046/j.1468-1293.2001.00058.x

    authors： le Roux CW,Beckles MA,Besser GM,Pinching AJ,Davison AG

    更新日期：2001-04-01 00:00:00

  • Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

    abstract：BACKGROUND:More than 10 years after the introduction of combination antiretroviral therapy (cART), we examined the trend in the proportion of deaths caused by end-stage liver disease (ESLD) in HIV-infected adults in France between 1995 and 2005. DESIGN AND METHODS:In 2005, 34 departments prospectively recorded all dea...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究

    doi：10.1111/j.1468-1293.2008.00686.x

    authors： Rosenthal E,Salmon-Céron D,Lewden C,Bouteloup V,Pialoux G,Bonnet F,Karmochkine M,May T,François M,Burty C,Jougla E,Costagliola D,Morlat P,Chêne G,Cacoub P,Mortavic\/Mortalité 2005 Study Group.

    更新日期：2009-05-01 00:00:00

  • Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women.

    abstract：OBJECTIVE:To assess the incidence and consequences of adverse reactions among African HIV-positive pregnant women treated with fixed-dose combinations of a nevirapine-containing antiretroviral (ARV) triple therapy. METHODS:A retrospective analysis of the clinical files of 703 HIV-1-positive pregnant women treated with...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2006.00386.x

    authors： Marazzi MC,Germano P,Liotta G,Guidotti G,Loureiro S,da Cruz Gomes A,Valls Blazquez MC,Narciso P,Perno CF,Mancinelli S,Palombi L

    更新日期：2006-07-01 00:00:00

  • Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection.

    abstract：OBJECTIVES:To study the impact of highly active antiretroviral therapy (HAART) on isotype switching and avidity maturation of HIV-1-specific immunoglobulin G (IgG) in patients with primary HIV-1 infection (PHI). METHODS:We studied the emergence and the evolution of anti-HIV IgG antibodies by quantitative immunoblottin...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究

    doi：10.1111/j.1468-1293.2006.00406.x

    authors： Adalid-Peralta L,Grangeot-Keros L,Rudent A,Ngo-Giang-Huong N,Krzysiek R,Goujard C,Deveau C,Le Gall M,Meyer L,Emilie D,Rouzioux C

    更新日期：2006-11-01 00:00:00

  • Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study).

    abstract：OBJECTIVES:Dyslipidaemic effects of antiretrovirals (ARVs) may contribute to increased cardiovascular risk (CR) in HIV-1-infected patients. The ARTEN (atazanavir/ritonavir on a background of tenofovir and emtricitabine vs. nevirapine on the same background, in naïve HIV-1-infected patients) study compared prospectively...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1111/j.1468-1293.2011.00917.x

    authors： Podzamczer D,Andrade-Villanueva J,Clotet B,Taylor S,Rockstroh JK,Reiss P,Domingo P,Gellermann HJ,de Rossi L,Cairns V,Soriano V

    更新日期：2011-07-01 00:00:00

  • An analysis of patients' understanding of 'routine' preoperative blood tests and HIV screening. Is no news really good news?

    abstract：OBJECTIVES:Many patients may believe that HIV screening is included in routine preoperative work-ups. We examined what proportion of patients undergoing preoperative blood testing believed that they had been tested for HIV. METHODS:All patients hospitalized for elective orthopaedic surgery between January and December...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2012.00993.x

    authors： Albrecht E,Frascarolo P,Meystre-Agustoni G,Farron A,Gilliard N,Darling K,Cavassini M

    更新日期：2012-08-01 00:00:00

  • Has testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK.

    abstract：OBJECTIVES:This paper examines changes in barriers to HIV testing amongst gay men. We compared data collected in 2000 and 2010 to assess changes in HIV testing behaviours, in community-level perceptions of barriers to HIV testing, and in the relative contributions of barrier measures. METHODS:Cross-sectional surveys w...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2012.01041.x

    authors： Flowers P,Knussen C,Li J,McDaid L

    更新日期：2013-02-01 00:00:00

  • Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects.

    abstract：:An HIV-infected man presented with a pneumonic illness following an episode of treated Pneumocystis carinii pneumonia (PCP). He had a rise in his CD4 count from 4 to 125 cells/microL on antiretroviral therapy prior to the onset of the second respiratory event. Bronchoalveolar lavage (BAL) revealed no pathogen, althoug...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1046/j.1468-1293.2002.00115.x

    authors： Barry SM,Lipman MC,Deery AR,Johnson MA,Janossy G

    更新日期：2002-07-01 00:00:00

  • Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients.

    abstract：OBJECTIVE:As a proactive diagnosis of diabetes mellitus (DM) may prevent the onset of severe complications, we used an oral glucose tolerance test (OGTT) to check for impaired glucose tolerance (IGT) and DM in patients with long-standing HIV infection and long durations of exposure to antiretroviral drugs with normal f...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2010.00860.x

    authors： Gianotti N,Visco F,Galli L,Barda B,Piatti P,Salpietro S,Bigoloni A,Vinci C,Nozza S,Gallotta G,Lazzarin A,Castagna A

    更新日期：2011-02-01 00:00:00

  • Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment.

    abstract：OBJECTIVES:Virological failure on first-line nonnucleoside reverse transcriptase inhibitor (NNRTI)-based treatment regimens has become a problem in HIV-infected children on long-term antiretroviral therapy (ART). Protease inhibitor (PI)-based regimens are therefore often given to children failing NNRTI-based regimens. ...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2012.01061.x

    authors： Wattanutchariya N,Sirisanthana V,Oberdorfer P

    更新日期：2013-04-01 00:00:00

  • The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium.

    abstract：OBJECTIVE:This study was designed to evaluate the effects of the HIV protease inhibitor lopinavir/ritonavir on gingival epithelium growth, integrity and differentiation. METHODS:Organotypic (raft) cultures of gingival keratinocytes were established and treated with a range of lopinavir/ritonavir concentrations. To exa...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2010.00863.x

    authors： Israr M,Mitchell D,Alam S,Dinello D,Kishel JJ,Meyers C

    更新日期：2011-03-01 00:00:00

  • Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.

    abstract：OBJECTIVES:People with HIV (PWHIV) are likely to need therapies for comorbidities as they age. We assessed risk of drug-drug interactions (DDIs) in PWHIV. METHODS:The Climate-HIV electronic recording system was used to cross-sectionally analyse records from PWHIV aged ≥ 18 years attending four UK HIV units with a curr...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12879

    authors： Okoli C,Schwenk A,Radford M,Myland M,Taylor S,Darley A,Barnes J,Fox A,Grimson F,Reeves I,Munshi S,Croucher A,Boxall N,Benn P,Paice A,van Wyk J,Khoo S

    更新日期：2020-09-01 00:00:00

  • CYP2B6 G516T genotyping in a UK cohort of HIV-positive patients: polymorphism frequency and influence on efavirenz discontinuation.

    abstract：OBJECTIVES:The nonnucleoside reverse transcriptase inhibitor (NNRTI) efavirenz undergoes phase I metabolism by the cytochrome P450 enzyme, CYP2B6. Previous studies outside of the United Kingdom have shown associations between the CYP2B6 polymorphism G516T and increased toxicity. This study aimed to develop a CYP2B6 G51...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2009.00718.x

    authors： Powers V,Ward J,Gompels M

    更新日期：2009-09-01 00:00:00

  • Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.

    abstract：BACKGROUND:Several studies have compared mitochondrial DNA (mtDNA) content in tissue from HIV-1-infected patients on highly active antiretroviral therapy with and without evidence of lipodystrophy, the diagnosis of which was based on subjective clinical assessment. OBJECTIVES:The aim of this study was to assess the ut...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2007.00428.x

    authors： Casula M,van der Valk M,Wit FW,Nievaard MA,Reiss P

    更新日期：2007-01-01 00:00:00

  • Trends in uptake of recently approved antiretrovirals within a national healthcare system.

    abstract：OBJECTIVE:The aim of the study was to describe Veterans Healthcare Administration (VHA) system-wide uptake of three HIV protease inhibitors: atazanavir, darunavir and tipranavir. METHODS:This retrospective cohort study evaluated VHA uptake of three target antiretrovirals and lopinavir/ritonavir in each complete 90-day...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2009.00764.x

    authors： Belperio PS,Mole LA,Boothroyd DB,Backus LI

    更新日期：2010-03-01 00:00:00

  • Knowledge of their children's HIV status in HIV-positive mothers attending a genitourinary medicine clinic in the UK.

    abstract：OBJECTIVES:To determine whether HIV-infected mothers knew the HIV status of their children, enabling the offer of targeted testing of children at risk. METHODS:All HIV-positive women attending the genitourinary medicine clinic at a district general hospital in the United Kingdom were asked whether they had children an...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2008.00556.x

    authors： Eisenhut M,Sharma V,Kawsar M,Balachandran T

    更新日期：2008-04-01 00:00:00

  • Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapy.

    abstract：OBJECTIVE:To measure the evolution of proviral HIV-1 DNA levels in patients receiving highly active antiretroviral therapy (HAART) compared to those treated with HAART plus interleukin-2 (IL-2) and hydroxyurea. DESIGN:Prospective randomised trial. METHODS:Twenty-two HIV-1 infected patients were randomly assigned to a...

    journal_title：HIV medicine

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1046/j.1468-1293.2001.00065.x

    authors： Lafeuillade A,Poggi C,Chadapaud S,Hittinger G,Khiri H,Halfon P

    更新日期：2001-07-01 00:00:00

  • HIV prevalence and HIV clinical outcomes of transgender and gender-diverse people in England.

    abstract：OBJECTIVES:We provide the first estimate of HIV prevalence among trans and gender-diverse people living in England and compare outcomes of people living with HIV according to gender identity. METHODS:We analysed a comprehensive national HIV cohort and a nationally representative self-reported survey of people accessin...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12987

    authors： Kirwan PD,Hibbert M,Kall M,Nambiar K,Ross M,Croxford S,Nash S,Webb L,Wolton A,Delpech VC

    更新日期：2021-02-01 00:00:00

  • Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.

    abstract：OBJECTIVES:Single nucleotide polymorphisms in the cytochrome P450 (CYP) 2B6 gene have been associated with high interindividual variation in efavirenz pharmacokinetics. However, clinical data on the relationship of CYP2B6 polymorphisms with the occurrence of efavirenz-induced central nervous system (CNS) symptoms are l...

    journal_title：HIV medicine

    pub_type： 杂志文章,随机对照试验

    doi：10.1111/hiv.12488

    authors： Gallien S,Journot V,Loriot MA,Sauvageon H,Morlat P,Reynes J,Reliquet V,Chêne G,Molina JM,ANRS 099 ALIZE trial study group.

    更新日期：2017-09-01 00:00:00

  • Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.

    abstract：BACKGROUND:The toxicities, cost and complexity of triple combinations warrant the search for other treatment options, such as boosted protease inhibitor (PI) monotherapy. MONotherapy AntiRetroviral Kaletra (MONARK) is the first randomized trial comparing lopinavir/ritonavir monotherapy to triple combination therapy wit...

    journal_title：HIV medicine

    pub_type： 杂志文章,随机对照试验

    doi：10.1111/j.1468-1293.2009.00752.x

    authors： Ghosn J,Flandre P,Cohen-Codar I,Girard PM,Chaix ML,Raffi F,Dellamonica P,Ngovan P,Norton M,Delfraissy JF,MONARK Study Group.

    更新日期：2010-02-01 00:00:00

  • Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response.

    abstract：OBJECTIVES:To investigate the concordance between any of the results of nine HIV-1 drug-resistance interpretation systems (ISs) and their ability to predict week 8 and week 24 virological responses to abacavir-containing combination therapy. PATIENTS AND METHODS:A total of 1306 HIV-infected patients with a viral load ...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2008.00523.x

    authors： Cozzi-Lepri A,Standardization and Clinical Relevance of HIV Drug Resistance Testing Project for the Forum for Collaborative HIV Research.

    更新日期：2008-01-01 00:00:00

  • Antiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy.

    abstract：OBJECTIVES:Apricitabine (ATC) is a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor (NRTI) with significant antiviral activity in vitro, including activity against HIV-1 with reverse transcriptase mutations that confer resistance to other NRTIs. ATC has shown promising antiviral activity and good...

    journal_title：HIV medicine

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1111/j.1468-1293.2010.00887.x

    authors： Cahn P,Altclas J,Martins M,Losso M,Cassetti I,Cooper DA,Cox S

    更新日期：2011-07-01 00:00:00

  • Cerebrospinal fluid HIV RNA in persons living with HIV.

    abstract：OBJECTIVES:Despite adequate suppression of plasma HIV RNA, viral escape in cerebrospinal fluid (CSF) is widely reported. Rates of CSF HIV RNA escape vary in the literature. In persons living with HIV (PLWH) undergoing lumbar puncture examination for clinical reasons, we assessed rates of CSF HIV RNA escape. METHODS:Pe...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12594

    authors： Di Carlofelice M,Everitt A,Muir D,Winston A

    更新日期：2018-05-01 00:00:00

  • Effect of testing experience and profession on provider acceptability of rapid HIV testing after implementation in public sexual health clinics in Sydney.

    abstract：OBJECTIVES:Rapid HIV testing (RHT) is well established in many countries, but it is new in Australia since a policy change in 2011. We assessed service provider acceptability of RHT before and after its implementation in four Sydney public sexual health clinics. METHODS:Service providers were surveyed immediately afte...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12209

    authors： Conway DP,Guy R,McNulty A,Couldwell DL,Davies SC,Smith DE,Keen P,Cunningham P,Holt M,Sydney Rapid HIV Test Study.

    更新日期：2015-05-01 00:00:00

  • Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure.

    abstract：OBJECTIVES:Two-drug antiretroviral regimens based on lamivudine (3TC) plus either a protease inhibitor (PI) or dolutegravir (DTG) are becoming increasingly popular in switch strategies. Our goal was to derive a predictive score for virological failure (VF). METHODS:We retrospectively analysed data for a cohort of 587 ...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12759

    authors： Borghetti A,Moschese D,Cingolani A,Baldin G,Speziale D,Ciccullo A,Lombardi F,Emiliozzi A,Belmonti S,Antinori A,Cauda R,Di Giambenedetto S

    更新日期：2019-10-01 00:00:00

  • Cardiovascular disease risk and its determinants in people living with HIV across different settings in South Africa.

    abstract：OBJECTIVES:Socio-economic factors and lifestyle are known to differ across geographies and populations, which may result in distinct risk profiles for cardiovascular disease (CVD). This study assessed carotid intima-media thickness (CIMT), a proxy for CVD, and its determinants in two groups of people living with HIV (P...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12831

    authors： Roozen G,Vos AG,Tempelman HA,Venter W,Grobbee DE,Scheuermaier K,Klipstein-Grobusch K

    更新日期：2020-07-01 00:00:00

  • Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.

    abstract：BACKGROUND:The world-wide AIDS epidemic is reflected in Western Europe in an increasing number of HIV-infected persons who originate from Africa. We describe the characteristics and response to antiretroviral therapy (ART) of HIV-infected patients born in Africa and living in France. METHODS:Analysis of data from the ...

    journal_title：HIV medicine

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1111/j.1468-1293.2007.00447.x

    authors： Breton G,Lewden C,Spire B,Salmon D,Brun-Vézinet F,Duong M,Allavena C,Leport C,Salamon R,APROCO COPILOTE ANRS CO8 Study Group.

    更新日期：2007-04-01 00:00:00

  • Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic.

    abstract：OBJECTIVES:To determine the proportion of skin/soft tissue infections (SSTIs) and to determine risks for MRSA infection caused by methicillin-resistant Staphylococcus aureus (MRSA) in HIV-infected out-patients. METHODS:We conducted a prospective study of SSTIs in HIV-infected out-patients. A questionnaire was used to ...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/j.1468-1293.2006.00394.x

    authors： Skiest D,Brown K,Hester J,Moore T,Crosby C,Mussa HR,Hoffman-Roberts H,Cooper T

    更新日期：2006-09-01 00:00:00

  • Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.

    abstract：OBJECTIVES:Direct-acting antiviral agents (DAAs) have become the standard of care for the treatment of chronic hepatitis C virus (HCV) infection. We aimed to assess treatment uptake and efficacy in routine clinical settings among HIV/HCV coinfected patients after the introduction of the first generation DAAs. METHODS:...

    journal_title：HIV medicine

    pub_type： 杂志文章

    doi：10.1111/hiv.12269

    authors： Schaerer V,Haubitz S,Kovari H,Ledergerber B,Ambrosioni J,Cavassini M,Stoeckle M,Schmid P,Decosterd L,Aouri M,Böni J,Günthard HF,Furrer H,Metzner KJ,Fehr J,Rauch A,Swiss HIV Cohort Study.

    更新日期：2015-11-01 00:00:00

  • Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.

    abstract：BACKGROUND:The addition of a low dose of ritonavir to protease inhibitors (PIs) has become a widespread strategy to improve PI pharmacokinetics. As resistance is a major barrier to long-term suppression, in salvage therapy genotype and/or phenotype scoring is currently used to predict the response. We evaluated the rel...

    journal_title：HIV medicine

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1111/j.1468-1293.2007.00464.x

    authors： Mallolas J,Blanco J,Labarga P,Vergara A,Ocampo A,Sarasa M,Arnedo M,López-Púa Y,García J,Juega J,Guelar A,Terrón A,Dalmau D,García I,Zárraga M,Martínez E,Carné X,Pumarola T,Escayola R,Gatell J

    更新日期：2007-05-01 00:00:00